🇺🇸 FDA
Patent

US 8536148

Disabling autophagy as a treatment for lysosomal storage diseases

granted A61KA61K31/00A61K31/52

Quick answer

US patent 8536148 (Disabling autophagy as a treatment for lysosomal storage diseases) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Sep 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Sep 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/00, A61K31/52, A61K31/7105, A61K31/713